BiotechTube
Home/Pipeline/BEX‑101

BEX‑101

Type‑2 Diabetes / Obesity

PreclinicalActive

Key Facts

Indication
Type‑2 Diabetes / Obesity
Phase
Preclinical
Status
Active
Company
Beximco Pharmaceuticals

About Beximco Pharmaceuticals

South Korean biotech leveraging AI‑driven small‑molecule drugs for metabolic and infectious diseases.

View full company profile

Therapeutic Areas

Metabolic DiseasesInfectious Diseases